Michal Šimíček
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Immune Cell Function and Interaction, Ubiquitin and proteasome pathways, Immune cells in cancer
Most-Cited Works
- → Mechanism of phospho-ubiquitin-induced PARKIN activation(2015)488 cited
- → Assembly and Specific Recognition of K29- and K33-Linked Polyubiquitin(2015)219 cited
- → Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition(2012)128 cited
- → OTUB 1 triggers lung cancer development by inhibiting RAS monoubiquitination(2016)102 cited
- → Venetoclax: A new wave in hematooncology(2018)99 cited
- → The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response(2013)99 cited
- → More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma(2022)69 cited
- → Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination(2019)65 cited
- → Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins(2018)63 cited
- → Limited efficacy of daratumumab in multiple myeloma with extramedullary disease(2021)50 cited